Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.

Nat Commun · 2023 · PMC9908867 · PMID 36755027

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

16a–b ), with borderline significant treatment effects for smoking, liver metastases and stage IVb stage in favor of ICI-chemo (Supplementary Fig. 16c ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.